Change forces.
Patent clearance.
Go-to-market for medical devices — freedom-to-operate scan and commercialisation pathways.
Four questions for any medical device innovation.
Step change
How discontinuous is this from current practice?
A tier — incremental, substitutive or categorical. A higher tier does not add benefit; it raises the bar the device must clear.
Market size
How much is winning worth at most?
A ledger of volume and price lines, each cited to a named source or declared a sensitivity axis, ending in an indicative all-payer range.
Adoptability
Will the people involved actually accept the change?
The single largest cost behind an actor who can say no. Costs are never added up across actors.
Capturability
Once adopted, can the value be kept?
A trimmed Porter reading — new entrants, rivalry, supplier and complementor power — plus two IP rows, obstruction and defensibility.
It's time we talked.
We're excited to hear from you.